Here's Why You Should Retain PacBio Stock in Your Portfolio Now

Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent fourth-quarter results, is expected to contribute further. However, long purchasing cycles and macroeconomic concerns persist.In the past six months, this Zacks Rank #3 (Hold) company’s shares have lost 28.1% compared with 9.7% decline of the industry. The S&P 500 Composite has also declined 1.6% in the said time frame.The renowned global provider o ...